Vanguard Group Inc. Acquires 326,623 Shares of CME Group Inc. (NASDAQ:CME)

Vanguard Group Inc. increased its holdings in CME Group Inc. (NASDAQ:CMEFree Report) by 1.0% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 34,243,090 shares of the financial services provider’s stock after acquiring an additional 326,623 shares during the quarter. Vanguard Group Inc. owned about 9.50% of CME Group worth $7,952,273,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors also recently modified their holdings of the company. SJS Investment Consulting Inc. increased its stake in shares of CME Group by 570.6% in the 4th quarter. SJS Investment Consulting Inc. now owns 114 shares of the financial services provider’s stock worth $26,000 after acquiring an additional 97 shares in the last quarter. Truvestments Capital LLC bought a new position in shares of CME Group in the 3rd quarter worth about $26,000. Dunhill Financial LLC grew its position in CME Group by 188.4% during the 3rd quarter. Dunhill Financial LLC now owns 124 shares of the financial services provider’s stock valued at $27,000 after purchasing an additional 81 shares during the last quarter. Financial Life Planners purchased a new stake in CME Group during the 4th quarter valued at about $32,000. Finally, Knuff & Co LLC purchased a new stake in CME Group during the 4th quarter valued at about $33,000. 87.75% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

CME has been the topic of several recent analyst reports. Citigroup downgraded shares of CME Group from a “buy” rating to a “neutral” rating and cut their price objective for the company from $255.00 to $250.00 in a research report on Monday, January 6th. Raymond James raised shares of CME Group from a “market perform” rating to an “outperform” rating and set a $287.00 price objective on the stock in a research report on Monday, March 10th. Piper Sandler increased their price objective on shares of CME Group from $250.00 to $258.00 and gave the company an “overweight” rating in a research report on Tuesday, January 7th. Morgan Stanley increased their price objective on shares of CME Group from $256.00 to $263.00 and gave the company an “equal weight” rating in a research report on Wednesday, February 19th. Finally, Erste Group Bank raised shares of CME Group to a “strong-buy” rating in a research report on Monday, March 17th. Four equities research analysts have rated the stock with a sell rating, eight have issued a hold rating, three have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $238.93.

Check Out Our Latest Report on CME

CME Group Stock Performance

CME opened at $263.35 on Monday. The company has a current ratio of 1.01, a quick ratio of 1.02 and a debt-to-equity ratio of 0.10. The company has a market cap of $94.90 billion, a price-to-earnings ratio of 27.23, a PEG ratio of 6.76 and a beta of 0.53. The company’s 50 day moving average is $246.50 and its 200 day moving average is $234.35. CME Group Inc. has a 12-month low of $190.70 and a 12-month high of $267.91.

CME Group (NASDAQ:CMEGet Free Report) last posted its quarterly earnings data on Wednesday, February 12th. The financial services provider reported $2.52 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.46 by $0.06. CME Group had a net margin of 57.52% and a return on equity of 13.62%. On average, equities research analysts predict that CME Group Inc. will post 10.49 EPS for the current year.

CME Group Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, March 26th. Shareholders of record on Friday, March 7th will be paid a dividend of $1.25 per share. This is a boost from CME Group’s previous quarterly dividend of $1.15. The ex-dividend date of this dividend is Friday, March 7th. This represents a $5.00 dividend on an annualized basis and a yield of 1.90%. CME Group’s dividend payout ratio (DPR) is presently 51.71%.

CME Group announced that its board has initiated a stock repurchase plan on Thursday, December 5th that authorizes the company to buyback $3.00 billion in outstanding shares. This buyback authorization authorizes the financial services provider to buy up to 3.4% of its stock through open market purchases. Stock buyback plans are usually an indication that the company’s board of directors believes its stock is undervalued.

Insiders Place Their Bets

In other CME Group news, COO Suzanne Sprague sold 1,500 shares of the firm’s stock in a transaction that occurred on Monday, March 3rd. The shares were sold at an average price of $256.83, for a total transaction of $385,245.00. Following the sale, the chief operating officer now owns 8,036 shares in the company, valued at approximately $2,063,885.88. This trade represents a 15.73 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Howard J. Siegel sold 10,000 shares of the firm’s stock in a transaction that occurred on Thursday, March 13th. The stock was sold at an average price of $260.00, for a total transaction of $2,600,000.00. Following the sale, the director now owns 21,873 shares in the company, valued at approximately $5,686,980. The trade was a 31.37 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 27,076 shares of company stock worth $6,871,496. Company insiders own 0.30% of the company’s stock.

About CME Group

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Featured Articles

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CMEFree Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.